Zhejiang Jiuzhou Pharmaceutical Co., Ltd.

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. has shown strong recent stock performance, with a notable increase on July 20, 2026. Despite longer-term challenges, the company maintains a solid return on equity and offers an appealing dividend yield, reflecting its resilience amid broader market fluctuations.

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. saw a notable decline in its stock price on July 17, 2026, amidst a challenging trading session. The company has experienced volatility, with recent performance metrics indicating both short-term losses and longer-term declines, while maintaining a market capitalization of approximately CNY 10,957 million.

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. saw a notable increase on July 10, 2026, contrasting with a decline in the broader market. Despite recent modest gains, the company has faced longer-term challenges. It operates in the Pharmaceuticals & Biotechnology sector, with a market capitalization of CNY 10,957 million.

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. has shown strong short-term performance, with significant increases over the past week and month, contrasting with the broader market's decline. However, the stock has faced long-term challenges, including notable year-to-date and three-year declines, while maintaining a market capitalization of CNY 10,957 million.

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. has seen a significant rise today, outperforming the China Shanghai Composite. Over the past week, the stock has shown positive momentum, although it has faced a slight downturn in the past month. The company maintains a strong market capitalization and a notable dividend yield.

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. saw a rise in stock performance on March 24, 2026, reaching an intraday high. Despite a year-to-date decline, the company has outperformed the broader index over the past year. It maintains a market capitalization of CNY 15,762 million and a price-to-earnings ratio of 26.00.

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. saw a significant stock decline, contrasting with broader market trends. Over the past week and month, the stock has experienced notable decreases, while year-to-date performance reflects a downturn. Despite challenges, the company has generated a return over the past year, though profits have declined.

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. faced a challenging trading session, with a notable stock decline. Over the past week, the stock decreased significantly, contrasting with the broader market. Long-term performance shows substantial declines, yet the company achieved a positive return over the past year despite decreased profits.

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. has seen a notable rise in stock performance, gaining 7.41% on October 15, 2025. The company reported record operating cash flow of CNY 1,519.92 million and maintains a dividend payout ratio of 63.98%, reflecting its strong position in the pharmaceuticals sector.

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. saw its stock decline significantly on October 13, 2025, reaching an intraday low. Despite mixed performance metrics, including a notable year-to-date gain and strong operating cash flow, the company has faced challenges over longer time frames while maintaining a solid market position.

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. saw a significant stock performance increase on September 25, 2025, reaching an intraday high. Over the past year, the company has shown impressive growth, recovering from previous declines and reporting strong financial metrics, including substantial operating cash flow and a notable dividend payout ratio.